Style | Citing Format |
---|---|
MLA | Tahamtan A, Tavakoliyaraki M, Salimi V. "Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients." Expert Review of Respiratory Medicine, vol. 14, no. 10, 2020, pp. 965-967. |
APA | Tahamtan A, Tavakoliyaraki M, Salimi V (2020). Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients. Expert Review of Respiratory Medicine, 14(10), 965-967. |
Chicago | Tahamtan A, Tavakoliyaraki M, Salimi V. "Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients." Expert Review of Respiratory Medicine 14, no. 10 (2020): 965-967. |
Harvard | Tahamtan A, Tavakoliyaraki M, Salimi V (2020) 'Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients', Expert Review of Respiratory Medicine, 14(10), pp. 965-967. |
Vancouver | Tahamtan A, Tavakoliyaraki M, Salimi V. Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients. Expert Review of Respiratory Medicine. 2020;14(10):965-967. |
BibTex | @article{ author = {Tahamtan A and Tavakoliyaraki M and Salimi V}, title = {Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients}, journal = {Expert Review of Respiratory Medicine}, volume = {14}, number = {10}, pages = {965-967}, year = {2020} } |
RIS | TY - JOUR AU - Tahamtan A AU - Tavakoliyaraki M AU - Salimi V TI - Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients JO - Expert Review of Respiratory Medicine VL - 14 IS - 10 SP - 965 EP - 967 PY - 2020 ER - |